Ligand validation:3KA2

2NC: N-{(2S)-2-[(N-acetyl-L-threonyl-L-isoleucyl)amino]hexyl}-L-norleucyl-L-glutaminyl-N~5~-[amino(iminio)methyl]-L-ornithinamide

2NC is a Ligand Of Interest in 3KA2 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3KA2_2NC_A_204	58%	19%	0.129	0.909	0.46	3.11	-	7	8	0	100%	0.3
3NXE_2NC_A_204	73%	58%	0.104	0.931	0.56	1.04	-	6	0	0	100%	0.963
3FSM_2NC_A_204	47%	50%	0.131	0.871	0.72	1.22	-	8	0	0	100%	0.963
3HLO_2NC_A_204	43%	52%	0.153	0.878	0.71	1.13	1	6	3	0	98%	0.9444
2O40_2NC_A_0	38%	49%	0.156	0.857	0.82	1.13	1	8	3	0	100%	0.963
3HZC_2NC_A_301	31%	47%	0.159	0.829	0.84	1.23	2	8	5	0	100%	0.963
2AOG_2NC_A_400	98%	55%	0.061	0.981	0.83	0.88	2	1	0	0	100%	0.9194
2AVM_2NC_B_300	95%	58%	0.077	0.982	0.69	0.91	1	2	1	0	100%	0.8007
2AOC_2NC_B_400	93%	53%	0.069	0.965	0.82	0.99	1	2	0	0	100%	0.9793
2AVQ_2NC_B_300	93%	20%	0.073	0.968	2.46	1.14	2	6	0	0	100%	0.8993
6O5A_2NC_A_201	89%	6%	0.078	0.957	2	3.28	16	28	10	0	100%	0.963

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.